SCH 13G

Company

Compass Therapeutics, Inc.

Filed

June 29, 2020

Accession Number

0001816338-20-000002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →